UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 8, 2025

PRO-DEX, INC.

(Exact name of registrant as specified in charter)

2361 McGaw Avenue

Irvine, California 92614

(Address of principal executive offices, zip code)

(949) 769-3200

(Registrant’s telephone number including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Exchange Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

Amendment to Credit Agreement & Amended and Restated Revolving Credit Note

On April 8, 2025, Pro-Dex, Inc. (the “Company”) entered into Amendment No. 6 to Amended and Restated Credit Agreement (the “Amendment”) with UMB Bank, N.A. D/B/A Minnesota Bank and Trust, a division of UMB Bank, N.A., successor-in-interest to Minnesota Bank and Trust, a division of HTLF Bank (“MBT”), which amends the Company’s Amended and Restated Credit Agreement with MBT (as amended, the “Credit Agreement”), as well as an Amended and Restated Revolving Credit Note with MBT (the “Revolving Note” and, together with the Amendment, the “Credit Agreement Amendments”). The Credit Agreement Amendments, among other things, increase the Company’s revolving line of credit (the “Revolving Loan”) with MBT from $7,000,000 to $11,000,000. The Revolving Loan may be borrowed against from time to time by the Company through its maturity date of December 29, 2026 on the terms set forth in the Credit Agreement. As of the date of this Current Report on Form 8-K, the Company has drawn $5,000,000 against the Revolving Loan, the entire amount of which remains outstanding. The Company paid a loan origination fee in the amount of $8,000 to MBT in conjunction with the Credit Agreement Amendments.

The Revolving Loan bears interest at an annual rate equal to the greater of (a) 4.0% or (b) SOFR for a one-month period from the website of the CME Group Benchmark Administration Limited, plus 2.5%. Commencing on the first day of each month after the Company initially borrows against the Revolving Loan and each month thereafter until maturity, the Company is required to pay all accrued and unpaid interest on the Revolving Loan through the date of payment. Any principal on the Revolving Loan that is not previously prepaid by the Company shall be due and payable in full on the maturity date (or earlier termination of the Revolving Loan).

Upon the occurrence and during the continuance of an event of default, the interest rate of the Revolving Loan is increased by 3% and MBT may, at its option, declare the entire balance of the Revolving Loan immediately due and payable in full.

The Credit Agreement and the Revolving Note contain representations and warranties, affirmative, negative and financial covenants, and events of default that are customary for loans of this type.

A copy of the Amendment and the Revolving Note are attached as exhibits to this Current Report on Form 8-K. The above descriptions are qualified by reference to the complete text of the Amendment and the Revolving Note. The representations, warranties, and covenants contained in those documents were made only for purposes of the transactions represented thereby as of the specific dates therein, are solely for the benefit of the Company and MBT, may be subject to limitations agreed upon by the Company and MBT, including, among others, being qualified by disclosures made for the purposes of allocating contractual risk between the parties instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors are not third-party beneficiaries under those documents and should not rely on the representations, warranties and covenants, or any descriptions thereof, as characterizations of the actual state of facts or condition of the Company. Moreover, information concerning the subject matter of representations and warranties contained in those documents may change after the date of those documents, which subsequent information may or may not be fully reflected in the Company’s public disclosures. Rather, investors and the public should look to the disclosures contained in the Company’s reports under the Securities Exchange Act of 1934, as amended, for information concerning the Company.

The disclosures concerning the Amendment and the Revolving Note contained in Item 1.01 above are incorporated into this Item 2.03 by this reference.

(d) Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.